Difficulty: Medium
Average Score: 75%
Practice
Among the following Group A beta hemolytic streptococcus has the highest resistance to
Correct answer
C
Rationale
In the context of pediatric cardiovascular disorders nursing, understanding the pharmacological management of infections, particularly those caused by Group A beta-hemolytic streptococcus, is crucial. The correct answer, option C - Erythromycin, is the highest resistance among the given antibiotics due to the emergence of macrolide-resistant strains of Group A streptococcus.
Erythromycin, a macrolide antibiotic, has been associated with increased resistance in Group A streptococcus over time. This resistance can limit the effectiveness of erythromycin in treating infections caused by this bacterium, making it the highest resistance among the options provided.
Looking at the incorrect options:
A) Cephalexin is a first-generation cephalosporin that is not typically associated with high resistance in Group A streptococcus.
B) Clindamycin is often an effective alternative for treating infections caused by Group A streptococcus, and resistance rates are generally lower compared to erythromycin.
D) Doxycycline, a tetracycline antibiotic, is not commonly used as a first-line treatment for Group A streptococcal infections in pediatric patients.
Educationally, this question highlights the importance of understanding antibiotic resistance patterns in pediatric patients with cardiovascular disorders, guiding healthcare providers in making evidence-based decisions regarding antibiotic selection to optimize patient outcomes while minimizing the risk of treatment failure. It underscores the need for healthcare professionals to stay updated on current resistance trends and guidelines to provide safe and effective care to pediatric patients.
Erythromycin, a macrolide antibiotic, has been associated with increased resistance in Group A streptococcus over time. This resistance can limit the effectiveness of erythromycin in treating infections caused by this bacterium, making it the highest resistance among the options provided.
Looking at the incorrect options:
A) Cephalexin is a first-generation cephalosporin that is not typically associated with high resistance in Group A streptococcus.
B) Clindamycin is often an effective alternative for treating infections caused by Group A streptococcus, and resistance rates are generally lower compared to erythromycin.
D) Doxycycline, a tetracycline antibiotic, is not commonly used as a first-line treatment for Group A streptococcal infections in pediatric patients.
Educationally, this question highlights the importance of understanding antibiotic resistance patterns in pediatric patients with cardiovascular disorders, guiding healthcare providers in making evidence-based decisions regarding antibiotic selection to optimize patient outcomes while minimizing the risk of treatment failure. It underscores the need for healthcare professionals to stay updated on current resistance trends and guidelines to provide safe and effective care to pediatric patients.